+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ophthalmic Eye Dropper Market Size, Share & Trends Analysis Report by Type (Unidose, Preserved, Preservative-free), Drug Type (Prescription drugs, OTC drugs), Treatment Type (Glaucoma, Allergies), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5936551
Description Jump to:
The global ophthalmic eye dropper market is anticipated to reach USD 20.02 billion by 2030, expanding at a CAGR of 6.01% from 2024 to 2030. The rising prevalence of eye disorders such as glaucoma, age-related macular degeneration, and eye syndrome among the aging population worldwide has surged the demand for efficient treatments delivered through eye droppers. Moreover, advancements in drug delivery technologies and the introduction of preservative-free eye drops have notably improved patient adherence to treatment regimens. For instance, preservative-free drops are considered safer and preferred by individuals with dry eyes, thus allowing more frequent use.

The rise in eye conditions such as cataracts, glaucoma, dry eye syndrome, and allergies has significantly bolstered the demand for ophthalmic eye drops. For instance, as reported by the National Glaucoma Research, over 3 million Americans live with glaucoma, out of which 2.7 million are affected by the prevalent open-angle glaucoma among those aged 40 and older. This surge in prevalence aligns with the aging global population, contributing to the increasing occurrence of these conditions. Consequently, there's a pressing necessity for effective treatments like eye drops to address these escalating eye health challenges.

The increased awareness about maintaining optimal eye health and regular eye check-ups has improved the demand for ophthalmic eye drops. This proactive approach helps treat ophthalmic issues quicker which allows eye care providers and eye drops manufacturing companies to assist. For instance, companies like Alcon and Bausch + Lomb have made special eye drops for different eye problems, thereby fueling the market growth.

Ophthalmic Eye Dropper Market Report Highlights

  • In 2023, the preserved multi-dose eye dropper type segment accounted for the largest revenue share due to the rising prevalence of ophthalmic diseases and eye infections, coupled with the increased demand for convenient and cost-effective eye drop solutions
  • Based on drug type, the prescription drugs segment has always accounted for the largest revenue share in 2023, due to the high prevalence of eye disorders requiring prescription-based treatments, driving the demand for specific medications delivered through eye droppers
  • Based on treatment type, the dry eye segment accounted for the largest revenue share in 2023, due to rising prevalence of dry eye syndrome globally, inspiring a higher demand for specialized treatments delivered through eye droppers catering to the eye condition
  • North America held the largest share of the market in 2023 due to technological advancements and increasing prevalence of eye disorders, coupled with a growing aging population in the region
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Drug Type
1.1.3. Treatment
1.1.4. Regional Scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for Primary Interviews in Europe
1.3.5.3. Data for Primary Interviews in Asia-Pacific
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Drug Type
2.2.3. Treatment Type
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Ophthalmic Eye Dropper Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of eye disorders
3.2.1.2. Technological advancements in drug delivery systems
3.2.1.3. Aging population and lifestyle changes
3.2.2. Market Restraint Analysis
3.2.2.1. Limited patient compliance
3.3. Ophthalmic Eye Dropper Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Ophthalmic Eye Dropper Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Unidose eye droppers
4.1.2. Preserved multi-dose eye droppers
4.1.3. Preservative-free multi-dose eye droppers
4.2. Type Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Ophthalmic Eye Dropper Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Unidose eye droppers
4.5.1.1. Unidose eye Droppers Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.2. Preserved multi-dose eye droppers
4.5.2.1. Preserved multi-dose eye droppers market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Preservative-free multi-dose eye droppers
4.5.3.1. Preservative-free multi-dose eye Droppers Market Estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Ophthalmic Eye Dropper Market: Drug Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Prescription drugs
5.1.2. OTC drugs
5.2. Drug Type Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Ophthalmic Eye Dropper Market by Drug Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Prescription drugs
5.5.1.1. Prescription drugs market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. OTC drugs
5.5.2.1. OTC drugs market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Ophthalmic Eye Dropper Market: Treatment Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Dry Eye
6.1.2. Glaucoma
6.1.3. Allergies
6.1.4. Conjunctivitis
6.1.5. Others
6.2. Treatment Type Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Ophthalmic Eye Dropper Market by Treatment Type Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Dry Eye
6.5.1.1. Dry eye market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Glaucoma
6.5.2.1. Glaucoma market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Allergies
6.5.3.1. Allergies market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Conjunctivitis
6.5.4.1. Conjunctivitis market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Ophthalmic Eye Dropper Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement scenario
7.5.1.5. U.S. market estimates and forecast, 2018-2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. Canada market estimates and forecast, 2018-2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement scenario
7.6.1.5. UK market estimates and forecast, 2018-2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Germany market estimates and forecast, 2018-2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. France market estimates and forecast, 2018-2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement scenario
7.6.4.5. Italy market estimates and forecast, 2018-2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement scenario
7.6.5.5. Spain market estimates and forecast, 2018-2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Norway market estimates and forecast, 2018-2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Sweden market estimates and forecast, 2018-2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement scenario
7.6.8.5. Denmark market estimates and forecast, 2018-2030 (USD Million)
7.7. Asia-Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. Japan market estimates and forecast, 2018-2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. China market estimates and forecast, 2018-2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. India market estimates and forecast, 2018-2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Australia market estimates and forecast, 2018-2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. South Korea market estimates and forecast, 2018-2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Thailand market estimates and forecast, 2018-2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Brazil market estimates and forecast, 2018-2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Mexico market estimates and forecast, 2018-2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Argentina market estimates and forecast, 2018-2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. South Africa market estimates and forecast, 2018-2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. UAE market estimates and forecast, 2018-2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement scenario
7.9.4.5. Kuwait market estimates and forecast, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. AptarGroup, Inc
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Silgan Dispensing Systems
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Alcon plc
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Pfizer
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bausch & Lomb Incorporated
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Novartis AG
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AbbVie Inc
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1 List of regulatory bodies for different countries
Table 2 Key companies’ product launches
Table 3 Key companies’ merger and acquisitions
Table 4 Key companies’ collaboration
Table 5 Other strategic initiatives of companies
Table 6 North America ophthalmic eye dropper market, by country, 2018-2030 (USD Million)
Table 7 North America ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 8 North America ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 9 North America ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 10 U.S. ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 11 U.S. ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 12 U.S. ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 13 Canada ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 14 Canada ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 15 Canada ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 16 Europe ophthalmic eye dropper market, by country, 2018-2030 (USD Million)
Table 17 Europe ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 18 Europe ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 19 Europe ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 20 UK ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 21 UK ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 22 UK ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 23 Germany ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 24 Germany ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 25 Germany ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 26 France ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 27 France ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 28 France ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 29 Italy ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 30 Italy ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 31 Italy ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 32 Spain ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 33 Spain ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 34 Spain ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 35 Norway ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 36 Norway ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 37 Norway ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 38 Sweden ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 39 Sweden ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 40 Sweden ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 41 Denmark ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 42 Denmark ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 43 Denmark ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 44 Asia-Pacific ophthalmic eye dropper market, by country, 2018-2030 (USD Million)
Table 45 Asia-Pacific ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 46 Asia-Pacific ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 47 Asia-Pacific ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 48 Japan ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 49 Japan ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 50 Japan ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 51 China ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 52 China ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 53 China ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 54 India ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 55 India ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 56 India ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 57 Australia ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 58 Australia ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 59 Australia ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 60 South Korea ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 61 South Korea ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 62 South Korea ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 63 Thailand ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 64 Thailand ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 65 Thailand ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 66 Latin America ophthalmic eye dropper market, by country, 2018-2030 (USD Million)
Table 67 Latin America ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 68 Latin America ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 69 Latin America ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 70 Brazil ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 71 Brazil ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 72 Brazil ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 73 Mexico ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 74 Mexico ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 75 Mexico ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 76 Argentina ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 77 Argentina ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 78 Argentina ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 79 Middle East & Africa ophthalmic eye dropper market, by country, 2018-2030 (USD Million)
Table 80 Middle East & Africa ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 81 Middle East & Africa ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 82 Middle East & Africa ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 83 South Africa ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 84 South Africa ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 85 South Africa ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 86 Saudi Arabia ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 87 Saudi Arabia ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 88 Saudi Arabia ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 89 UAE ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 90 UAE ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 91 UAE ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
Table 92 Kuwait ophthalmic eye dropper market, by type, 2018-2030 (USD Million)
Table 93 Kuwait ophthalmic eye dropper market, by drug type, 2018-2030 (USD Million)
Table 94 Kuwait ophthalmic eye dropper market, by treatment type, 2018-2030 (USD Million)
List of Figures
Fig. 1 Ophthalmic eye dropper market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement process
Fig. 4 Primary research pattern
Fig. 5 Ophthalmic eye dropper market snapshot, 2023 (USD Million)
Fig. 6 Segment snapshot, USD Million
Fig. 7 Competitive landscape snapshot
Fig. 8 Penetration & growth prospect mapping, by product
Fig. 9 Market driver analysis (Current & future impact)
Fig. 10 Market restraint analysis (Current & future impact)
Fig. 11 Ophthalmic eye dropper market, type outlook key takeaways (USD Million)
Fig. 12 Ophthalmic eye dropper market: type movement analysis (USD Million), 2023 & 2030
Fig. 13 Unidose eye droppers market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 14 Preserved multi-dose eye droppers market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 15 Preservative-free multi-dose eye droppers market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 16 Ophthalmic eye dropper market, drug type outlook key takeaways (USD Million)
Fig. 17 Ophthalmic eye dropper market: Drug type movement analysis (USD Million), 2023 & 2030
Fig. 18 Prescription drugs market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 OTC drugs market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Ophthalmic eye dropper market, treatment type outlook key takeaways (USD Million)
Fig. 21 Ophthalmic eye dropper market: Treatment type movement analysis (USD Million), 2023 & 2030
Fig. 22 Dry eye market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 Glaucoma market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Allergies market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Conjunctivitis market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Others market revenue estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Ophthalmic eye dropper market : Regional key takeaways (USD Million)
Fig. 28 Ophthalmic eye dropper market: Regional outlook, 2023 & 2030, USD Million
Fig. 29 North America ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 U.S. ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Canada ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Europe ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 UK ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Germany ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 France ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Spain ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Italy ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Sweden ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Norway ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Denmark ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Asia-Pacific ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 China ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Japan ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 India ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 South Korea ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Australia ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Thailand ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Latin America ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Brazil ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Mexico ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Argentina ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Middle East and Africa ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 South Africa ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Saudi Arabia ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 UAE ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Kuwait ophthalmic eye dropper market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • AptarGroup, Inc
  • Silgan Dispensing Systems
  • Alcon plc
  • Pfizer
  • Bausch & Lomb Incorporated
  • Novartis AG
  • AbbVie Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 13.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.02 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Ophthalmic Eye Dropper Global Market Report 2024 - Product Image

Ophthalmic Eye Dropper Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region - Product Image

Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region

  • Report
  • 200 Pages
  • Global
From
Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030 - Product Image

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Artificial Tears - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Artificial Tears - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Ophthalmic Drugs Market by Dispense Type, Disease Condition, Products, Dosage Form, Distribution - Global Forecast 2025-2030 - Product Image

Ophthalmic Drugs Market by Dispense Type, Disease Condition, Products, Dosage Form, Distribution - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.